
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5508518
[patent_doc_number] => 20090081725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Compositions of pamps and Listeria monocytogenes and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/498926
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 18475
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498926 | Compositions of pamps and Listeria monocytogenes and methods of use | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5050902
[patent_doc_number] => 20070031447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides'
[patent_app_type] => utility
[patent_app_number] => 11/494755
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12898
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11494755
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/494755 | Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides | Jul 26, 2006 | Abandoned |
Array
(
[id] => 5557785
[patent_doc_number] => 20090269362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Method for Controlling Immunodominance'
[patent_app_type] => utility
[patent_app_number] => 11/996907
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8519
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996907 | Method for Controlling Immunodominance | Jul 24, 2006 | Abandoned |
Array
(
[id] => 5302896
[patent_doc_number] => 20090297548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING ANTHRAX SPORE-ASSOCIATED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/996160
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 37590
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297548.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996160
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996160 | IMMUNOGENIC COMPOSITIONS COMPRISING ANTHRAX SPORE-ASSOCIATED PROTEINS | Jul 18, 2006 | Abandoned |
Array
(
[id] => 5342752
[patent_doc_number] => 20090181402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD'
[patent_app_type] => utility
[patent_app_number] => 11/995523
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13672
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181402.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995523 | COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD | Jul 13, 2006 | Abandoned |
Array
(
[id] => 5538733
[patent_doc_number] => 20090220538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => ' VACCINE FOR STAPHYLOCOCCAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/067458
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6136
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220538.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067458
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067458 | VACCINE FOR STAPHYLOCOCCAL INFECTIONS | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5835343
[patent_doc_number] => 20060247174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Use of a peptide'
[patent_app_type] => utility
[patent_app_number] => 11/485692
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4099
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247174.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485692 | Use of a peptide | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5242127
[patent_doc_number] => 20070020620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Compositions and methods for coupling a plurality of compounds to a scaffold'
[patent_app_type] => utility
[patent_app_number] => 11/486646
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13655
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486646 | Compositions and methods for coupling a plurality of compounds to a scaffold | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5515377
[patent_doc_number] => 20090215684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Use of BPI Protein for Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/995098
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9955
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995098 | Use of BPI Protein for Treatment of Diseases | Jul 6, 2006 | Abandoned |
Array
(
[id] => 4675689
[patent_doc_number] => 20080213318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Malaria MSP-1 C-terminal enhanced subunit vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/481709
[patent_app_country] => US
[patent_app_date] => 2006-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18530
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213318.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481709 | Malaria MSP-1 C-terminal enhanced subunit vaccine | Jul 2, 2006 | Abandoned |
Array
(
[id] => 5835340
[patent_doc_number] => 20060247171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Use of a peptide'
[patent_app_type] => utility
[patent_app_number] => 11/478107
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4095
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478107
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478107 | Use of a peptide | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5270979
[patent_doc_number] => 20090074755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Use of panton-valentine leukocidin for treating and preventing staphylococcus infections'
[patent_app_type] => utility
[patent_app_number] => 11/451608
[patent_app_country] => US
[patent_app_date] => 2006-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16608
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11451608
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/451608 | Use of panton-valentine leukocidin for treating and preventing staphylococcus infections | Jun 12, 2006 | Abandoned |
Array
(
[id] => 5270936
[patent_doc_number] => 20090074712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Methods for Treatment and Prevention of Infection'
[patent_app_type] => utility
[patent_app_number] => 11/914776
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8923
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074712.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914776 | Methods for Treatment and Prevention of Infection | May 18, 2006 | Abandoned |
Array
(
[id] => 5391223
[patent_doc_number] => 20090208536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis'
[patent_app_type] => utility
[patent_app_number] => 11/920521
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2719
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208536.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920521 | Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis | May 2, 2006 | Abandoned |
Array
(
[id] => 5368793
[patent_doc_number] => 20090306352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Basic Protein Purification Tags from Thermophilic Bacteria'
[patent_app_type] => utility
[patent_app_number] => 11/911563
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12941
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911563 | Basic protein purification tags from thermophilic bacteria | Apr 9, 2006 | Issued |
Array
(
[id] => 6000708
[patent_doc_number] => 20110117104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'MONOCLONAL ANTIBODY SPECIFIC TO ANTHRAX TOXIN'
[patent_app_type] => utility
[patent_app_number] => 11/908249
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11752
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908249
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908249 | Monoclonal antibody specific to anthrax toxin | Mar 9, 2006 | Issued |
Array
(
[id] => 5415775
[patent_doc_number] => 20090041662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method'
[patent_app_type] => utility
[patent_app_number] => 11/884876
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5912
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884876 | Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method | Feb 21, 2006 | Abandoned |
Array
(
[id] => 557347
[patent_doc_number] => 07468427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-23
[patent_title] => 'Antibodies to PRO1275 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 11/341175
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41789
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/468/07468427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341175
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341175 | Antibodies to PRO1275 polypeptide | Jan 26, 2006 | Issued |
Array
(
[id] => 4663123
[patent_doc_number] => 20080254030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Use of Baff to Treat Th2-Mediated Conditions'
[patent_app_type] => utility
[patent_app_number] => 11/814959
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6468
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814959 | Use of Baff to Treat Th2-Mediated Conditions | Jan 26, 2006 | Abandoned |
Array
(
[id] => 5618985
[patent_doc_number] => 20060188518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Glycoconjugate vaccines for use in immune-compromised populations'
[patent_app_type] => utility
[patent_app_number] => 11/338900
[patent_app_country] => US
[patent_app_date] => 2006-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8197
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188518.pdf
[firstpage_image] =>[orig_patent_app_number] => 11338900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/338900 | Glycoconjugate vaccines for use in immune-compromised populations | Jan 24, 2006 | Issued |